Trials / Unknown
UnknownNCT01717105
Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
Observational Post-authorization Prospective Study to Characterize the Incidence of Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Advanced Non-small Cell Lung Cancer Patients and Their Clinical Management in Galicia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 225 (estimated)
- Sponsor
- Grupo Gallego de Cancer de Pulmon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present study has been designed in order to characterize the incidence of patients with advanced non-small cell lung cancer (NSCLC) carrying epidermal growth factor receptor (EGFR) positive mutations and their clinical management in Galicia.
Conditions
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2012-12-01
- Completion
- 2013-02-01
- First posted
- 2012-10-30
- Last updated
- 2012-11-06
Locations
9 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01717105. Inclusion in this directory is not an endorsement.